Promoting and facilitating strategies to improve cardiovascular health worldwide
Promoting and facilitating strategies to improve cardiovascular health worldwide
Promoting and facilitating strategies to improve cardiovascular health worldwide
Promoting and facilitating strategies to improve cardiovascular health worldwide
-
Conferences & Events
Organising high level conferences featuring presentations, seminars and discussions and attended by world-renowned consultants.
-
Webinars & e‑Learning
Specific training and best-practice modules, including ISCP on-demand webinars and ISCP-endorsed webinars
-
Expert Reviews & Analysis
Expert Reviews, Opinions and Brief Reports. Independent summary information to keep you up to date with the latest research.
-
Drug Interaction Database
A reference tool for cardiovascular physicians and surgeons, pharmacists, pharmacologists, scientists and medical practitioners.
ISCP ANNUAL GENERAL ASSEMBLY
The ISCP yearly General Assembly will take place in Amsterdam on Saturday 26th August at 13.00-14.30 CEST. If you are a Full Member and would like to attend, please let us know in advance as it will help us organise the logistics.
For those not able to attend in person, the session will be broadcasted live over Zoom. If you wish to attend online, please send an email to lourdesmarenco@icpcardio.org so you are added to the list and receive the login details to the meeting.
ESC 2023 @AMSTERDAM
The most expected event of the year in the cardiology world is taking place in Amsterdam this August and we are thrilled to confirm that we will be participating with a booth (A670) within the International Associations Row in the exhibition area. If you are planning on attending please come and say hi, would love to meet you!
ISCP will also participate in the scientific sessions. We will present a joint session ESC-ISCP titled “RNA-based therapy in cardiovascular disease: ready for prime time!” so look up for this session on the meeting’s programme and make sure not to miss it!
A-Z of CV Pharmacotherapy:
ISCP Webinar Series
Our first five webinars produced in collaboration with our partners Radcliffe Cardiology are now available to view in the Webinars On Demand section:
1- Ferric Carboxymaltose: Ironing Out the Issues Around Heart Failure-Related Readmissions,
2- Inclisiran: A Jab Goes a Long Way,
3- Edoxaban: ENGAGEing in Individualisation of DOACs,
4- Valsartan Sacubitril: Has our PARADIGM shifted?,
5- Clopidogrel or Ticagrelor: Why, When, for Whom?, and
Details of future webinars will become available in Upcoming webinars very soon, including the next series of our own A to Z of CV Pharmacotherapy programme
Have you watched one or more of the above sessions? We value your opinion. Take 3 minutes to give us feedback on the series.
Upcoming Events
Highlights
The latest reviews, resources and expert analysis from our website.
newsfeed
Potassium cardioprotective in people with an ICD
Posted on August 29, 2025
Increased potassium intake and dietary guidance reduced risk for adverse events in patients with an implantable cardioverter defibrillator and may be an... more
August is Civic Health Month: Let’s check our voter registration and register to vote
Posted on August 29, 2025
Our vote is our voice and, as busy physicians, Civic Health Month is the perfect time to ensure we are registered to... more
Remote atrial fibrillation screening confers ‘modest’ benefits
Posted on August 29, 2025
A remote screening strategy for asymptomatic atrial fibrillation involving use of an ECG patch for continuous ambulatory monitoring conferred a modest increase... more
Digitoxin improves outcomes in some patients with heart failure
Posted on August 29, 2025
In patients with heart failure with reduced ejection fraction on guideline-directed medical therapy, digitoxin conferred lower rates of death or worsening HF... more
ISCP book series
Current Cardiovascular Therapy
Kaski, Juan Carlos.
Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...
-
Antiplatelet and Anticoagulation Therapy
A. Ferro, D.A. Garcia (Eds.)
-
Pharmacological Treatment of Acute Coronary Syndromes
Avanzas, Pablo; Clemmensen, Peter(Eds.)
-
Atrial Fibrillation Therapy
Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)
board of directors
Providing a leadership and advocacy role amongst members of their national societies.
-
Alberto Lorenzatti
VP / President Elect
Affiliations/Memberships Founder and Past President of the Argentine Lipids Society (2003-2005); Current Chair of the Americas Federation from the International Atherosclerosis Society (IAS). Research Interests Atherosclerosis Lipid Metabolism Inflammation and CHD more
-
Georg Noll
Treasurer
Georg Noll is a specialist in General Internal Medicine and Cardiology at Heart Clinic Zurich. He was Associate Professor of Cardiology (more…) more
-
Pablo Avanzas
Secretary
Affiliations/Memberships Consultant in Invasive Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain Fellow of (more…) more
-
Sang Hong Baek
President
Professor Sang Hong Baek is Director of Heart Failure and Transplantation Programme and Preventive Cardiology at Seoul St. Mary's (more…) more
